Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Covington
UBS
Julphar
Moodys
Mallinckrodt

Generated: August 25, 2019

DrugPatentWatch Database Preview

Patent: 8,597,680

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,597,680
Title:Microtablets for drug delivery
Abstract: Methods and systems are provided for making a drug microtablet. The method includes loading a lyophilization capillary channel with a liquid drug solution; lyophilizing the liquid drug solution in the lyophilization capillary channel to produce a lyophilized drug formulation; compressing the lyophilized drug formulation in the lyophilization capillary channel, or in a compression capillary channel, to form a microtablet; and ejecting the microtablet from the lyophilization capillary channel or compression capillary channel. The methods and systems may provide drug microtablets having improved content uniformity and reduced weight variability.
Inventor(s): Coppeta; Jonathan R. (Windham, NH), Dyer; Robert (Concord, MA), Stevenson; Cynthia L. (Mountain View, CA)
Assignee: On Demand Therapeutics, Inc. (Tyngsboro, MA)
Application Number:13/672,043
Patent Claims:see list of patent claims

Details for Patent 8,597,680

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Regeneron Pharmaceuticals EYLEA aflibercept INJECTABLE; INJECTION 125387 001 2011-11-18   Try a Free Trial On Demand Therapeutics, Inc. (Tyngsboro, MA) 2032-02-03 RX search
Genentech LUCENTIS ranibizumab INJECTABLE; INJECTION 125156 001 2006-06-30   Try a Free Trial On Demand Therapeutics, Inc. (Tyngsboro, MA) 2032-02-03 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Try a Free Trial On Demand Therapeutics, Inc. (Tyngsboro, MA) 2032-02-03 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Try a Free Trial On Demand Therapeutics, Inc. (Tyngsboro, MA) 2032-02-03 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,597,680

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2013039621 Mar 21, 2013
World Intellectual Property Organization (WIPO) 2013039621 May 08, 2014
United States of America 2013064886 Mar 14, 2013
United States of America 8192659 Jun 05, 2012
United States of America 8317507 Nov 27, 2012
European Patent Office 2755686 Jul 22, 2015
European Patent Office 2755686 Jul 23, 2014
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Baxter
Chubb
QuintilesIMS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.